SCHEMBL660917

SCHEMBL660917

O=C(CN1C=CCC(C(=O)c2ccccc2)=C1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MGAM O43451 1/20 0.38
AMY1A P0DUB6 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
CES1 P23141 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27854995 0.90 ALDH1A1 (0.41) ALDH1A1RAB9ASMN1; SMN2MGAMAMY1A
SCHEMBL298474 0.86 SMN1; SMN2 (0.40) ALDH1A1RAB9ASMN1; SMN2MGAMAMY1A
SCHEMBL660154 0.85 SMN1; SMN2 (0.39) ALDH1A1RAB9ASMN1; SMN2MGAMAMY1A
SCHEMBL27871677 0.85 ALDH1A1 (0.38) ALDH1A1RAB9ASMN1; SMN2MGAMAMY1A
SCHEMBL658507 0.83 TSHR (0.42) ALDH1A1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL287206 0.83 PTGS2 (0.47) ALDH1A1SMN1; SMN2GAAHPGDKDM4E
SCHEMBL7805087 0.81 HDAC1 (0.40) ALDH1A1RAB9ASMN1; SMN2MGAMAMY1A
SCHEMBL27854950 0.81 ADRA2C (0.35) ALDH1A1RAB9ASMN1; SMN2MGAMAMY1A
SCHEMBL660680 0.80 SMN1; SMN2 (0.40) ALDH1A1SMN1; SMN2GSK3AGSK3BHPGD
SCHEMBL660364 0.80 PDCD1 (0.43) ALDH1A1RAB9ASMN1; SMN2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT ALDH1A1 676/4885RAB9A 2179/4885SMN1; SMN2 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.